trending Market Intelligence /marketintelligence/en/news-insights/trending/g23aJytC3J0z3OeH0cfaKw2 content esgSubNav
In This List

Mutual of Omaha to cover Mass. residents taking HIV prevention drug

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Insurance Underwriting Transformed How Insurers Can Harness Probability of Default Models for Smarter Credit Decisions

Blog

The World's Largest P&C Insurers, 2023


Mutual of Omaha to cover Mass. residents taking HIV prevention drug

Mutual of Omaha Insurance Co. agreed to cover Massachusetts residents using the HIV prevention drug Truvada for pre-exposure prophylaxis.

The company changed its underwriting practices after an investigation by the Massachusetts Attorney General's office and a separate lawsuit filed by the group GLBTQ Legal Advocates & Defenders. The modification means that Truvada will no longer be a disqualifier for any type of accident, life, sickness or health insurance, including long-term care insurance.

Truvada is a tablet containing two types of antiretroviral medication that block HIV from replicating in the body. The drug is a product of Gilead Sciences Inc.